drugset / Trial / NCT00437307
Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse
RandomizedParallel-groupOpen-labelTreatment
Summary
Determination of progression free survival after 12 months of FU Determination of total survival, response and quality of life
Timeline
- Start
- 2007-03
- Primary completion
- 2013-07
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Topotecan | Small molecule | 0.75 mg/m2 | — |
| Background | Carboplatin | Small molecule | — | — |